Liver disease in the HIV-infected individual
- PMID: 20851211
- PMCID: PMC2997131
- DOI: 10.1016/j.cgh.2010.08.024
Liver disease in the HIV-infected individual
Abstract
Since the advent of effective antiretroviral therapy (ART) for human immunodeficiency virus-1 (HIV), there has been a substantial decrease in deaths related to acquired immunodeficiency syndrome (AIDS). However, in the ART era, liver disease is now the most common non-AIDS-related cause of death among HIV-infected patients, accounting for 14%-18% of all deaths in this population and almost half of deaths among hospitalized HIV-infected patients. Just as the burden of non-AIDS morbidity and mortality has changed in the ART era, the types of liver disease the clinician is likely to encounter among these patients have changed as well. This review will discuss the causes of liver disease in the HIV-infected population in the ART era, including chronic hepatitis C virus, chronic hepatitis B virus, medication-related hepatotoxicity, alcohol abuse, nonalcoholic fatty liver disease, and AIDS-related liver diseases.
Copyright © 2010 AGA Institute. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Prevalence and factors associated with liver test abnormalities among human immunodeficiency virus-infected persons.Clin Gastroenterol Hepatol. 2010 Feb;8(2):183-91. doi: 10.1016/j.cgh.2009.09.025. Epub 2009 Oct 2. Clin Gastroenterol Hepatol. 2010. PMID: 19800985 Free PMC article.
-
Antiretroviral Therapies for Human Immunodeficiency Virus and Liver Disease: Challenges and opportunities.Ann Hepatol. 2020 Mar-Apr;19(2):121-122. doi: 10.1016/j.aohep.2020.02.004. Ann Hepatol. 2020. PMID: 32138869
-
The burden of liver disease in human immunodeficiency virus-infected patients.Semin Liver Dis. 2012 May;32(2):103-13. doi: 10.1055/s-0032-1316473. Epub 2012 Jul 3. Semin Liver Dis. 2012. PMID: 22760649 Review.
-
Increasing burden of liver disease in patients with HIV infection.Lancet. 2011 Apr 2;377(9772):1198-209. doi: 10.1016/S0140-6736(10)62001-6. Lancet. 2011. PMID: 21459211 Review.
-
Predictors of severe hepatotoxicity among retroviral infected adults on HAART regimen in Ilubabor Zone, Southwest Ethiopia.Sci Rep. 2024 Apr 11;14(1):8473. doi: 10.1038/s41598-024-57900-7. Sci Rep. 2024. PMID: 38605149 Free PMC article.
Cited by
-
Optimizing cardiometabolic risk in people living with human immunodeficiency virus: A deep dive into an important risk enhancer.Am J Prev Cardiol. 2024 Oct 28;20:100888. doi: 10.1016/j.ajpc.2024.100888. eCollection 2024 Dec. Am J Prev Cardiol. 2024. PMID: 39552706 Free PMC article. Review.
-
Risk factors associated with post-tuberculosis sequelae: a systematic review and meta-analysis.EClinicalMedicine. 2024 Oct 21;77:102898. doi: 10.1016/j.eclinm.2024.102898. eCollection 2024 Nov. EClinicalMedicine. 2024. PMID: 39502524 Free PMC article.
-
Prevalence of metabolic dysfunction-associated steatotic liver disease in people living with HIV and on antiretroviral treatment: A systematic review and meta-analysis protocol.Health Sci Rep. 2024 Oct 28;7(11):e70071. doi: 10.1002/hsr2.70071. eCollection 2024 Nov. Health Sci Rep. 2024. PMID: 39474343 Free PMC article.
-
Hepatitis B and C Virus Co-Infection and Their Association With Liver Disease in Persons With HIV in Nigeria.J Int Assoc Provid AIDS Care. 2024 Jan-Dec;23:23259582241292511. doi: 10.1177/23259582241292511. J Int Assoc Provid AIDS Care. 2024. PMID: 39469965 Free PMC article.
-
Comparison of non-invasive methods of assessing liver fibrosis in combination ART-experienced Zimbabweans.South Afr J HIV Med. 2019 Apr 11;20(1):844. doi: 10.4102/sajhivmed.v20i1.844. eCollection 2019. South Afr J HIV Med. 2019. PMID: 39391097 Free PMC article.
References
-
- Schneider MF, Gange SJ, Williams CM, et al. Patterns of the hazard of death after AIDS through the evolution of antiretroviral therapy: 1984-2004. AIDS. 2005;19(17):2009–2018. - PubMed
-
- Palella FJ, Jr., Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998;338(13):853–860. - PubMed
-
- Palella FJ, Jr., Baker RK, Moorman AC, et al. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr. 2006;43(1):27–34. - PubMed
-
- Group TDCoAEoA-HIVdS Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D study. AIDS. 2010;24(10):1537–1548. - PubMed
-
- Bica I, McGovern B, Dhar R, et al. Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis. 2001;32(3):492–497. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
